Back to Search
DAVID BROWN, MD
MD
Pediatric Cardiology Physician
NPI: 1952392888IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatric Cardiology PhysicianPrimary
Pediatrics — Pediatric Cardiology
Code: 2080P0202X
159958(MA)
Pediatrics Physician
Pediatrics
Code: 208000000X
159958(MA)
CMS Specialties
PrimaryPEDIATRIC MEDICINE
Additional
CARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
HARVARD MEDICAL SCHOOL
Class of 1996
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial).
PMID 24518078·Br J Ophthalmol·2014
4-observational
Aflibercept (eylea) for age-related macular degeneration.
PMID 22354219·Med Lett Drugs Ther·2012
6-review
Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration.
PMID 22300011·Expert Opin Pharmacother·2012
6-review
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
PMID 21526923·N Engl J Med·2011
4-observational
Fundus autofluorescence and visual acuity in central serous chorioretinopathy.
PMID 21055816·Ophthalmology·2011
8-other
Vascular endothelial growth factor Trap-Eye for diabetic macular oedema.
PMID 19174397·Br J Ophthalmol·2009
8-other
Predicted biological activity of intravitreal VEGF Trap.
PMID 18356264·Br J Ophthalmol·2008
4-observational
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
PMID 17386270·Am J Ophthalmol·2007
3-trial
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
PMID 17021319·N Engl J Med·2006
4-observational
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
PMID 16458968·Ophthalmology·2006
5-case
Cystoid macular degeneration in chronic central serous chorioretinopathy.
PMID 12652224·Retina·2003
8-other
VEGF-Trap: a VEGF blocker with potent antitumor effects.
PMID 12177445·Proc Natl Acad Sci U S A·2002
7-preclinical
Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
PMID 11927845·Retina·2002
3-trial
Regulation of the V-ATPase in kidney epithelial cells: dual role in acid-base homeostasis and vesicle trafficking.
PMID 19448085·J Exp Biol·2009
6-review
Sensing, signaling and sorting events in kidney epithelial cell physiology.
PMID 19170982·Traffic·2009
6-review
Limitations of risk score models in patients with acute chest pain.
PMID 19041532·Am J Emerg Med·2009
8-other
Phosphorylation events and the modulation of aquaporin 2 cell surface expression.
PMID 18695390·Curr Opin Nephrol Hypertens·2008
6-review
Aquaporins and vasopressin signaling in kidney health and disease: introduction.
PMID 18519082·Semin Nephrol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 LONGWOOD AVE
BOSTON, MA 02115 - Phone
- (617) 355-7893
Quick Facts
- NPI
- 1952392888
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 30
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile